Comparative Effects of Pilates Breathing and Pursed Lip Breathing on Chest Expension and Peak Expiratory Flow Rate in Patients With Chronic Obstructive Lung Disease

NCT ID: NCT07177976

Last Updated: 2025-10-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-15

Study Completion Date

2026-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic Obstructive Pulmonary Disease is a particular type of irreversible disease that may damage or obstruct airways and make it difficult to breath. This respiratiry condition may lead to shallow breathing.

Breathing exercisers help to manage hyperventilation often seen in COPD patients. To handle respiratory complications patients are advised to practice breathing techniques along with pharmacological management

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chronic Obstructive pulmonary Disease is a particular type of irreversible disease that may damage or obstruct airways and make it difficult to breath. This respiratory condition may lead to shallow breathing.

Breathing exercises help to manage hyperventilation often seen in copd patients. To handle respiratory complications patients are advised to practice brathing techniques along with pharmacological management.

Total 46 participants are allocated divided into two group. Group A will perform Pilates breathing along with pharmacological management and group B will perform Pursed-lip breathing along with pharmacological management.

Hence objective of study is to compare the effects of pilates breathing techniques along with pharmacological management versus pursed-lip breathing along with pharmacological management on chest expansion, peak expiratory flow rate, dyspnea and quality of life in patients with chronic obstructive lung disease

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Disease, Chronic Obstructive (COPD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This is a randomized controlled trial having two groups. One group (interventional group) wil receive Pilates breathing along with pharmacological management and the other group (control group) will perform Pursed-lip breathing along with pharmacological management.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Patients in this group will receive Pilates breathing techniques along with pharmacological management for total of 3 weeks.

Two sessions per week will be supervised by physiotherapist and 5 days at home. A home diary will be provided in order to ensure and follow-up of the participants are performing breathing exercises at home.

Group Type EXPERIMENTAL

Pilates Breathing Technique along with standard pharmacological management

Intervention Type PROCEDURE

Patients in this group will receive pilates breathing technique along with pharmacological management.

A total 3 weeks protocol will be followed in which 2 seesions per week will be supervised by physiotherapist and 5 days at home.

Pilates breathing will be performed in sitting or supine position. The patient will place a hand over the Lower Posterior rib Cage and inhale through the nose.

While breathing they will actively contract the Transverse Abdominis (TrA) as if preparing for punch or holding in urine and engaging the pelvic floor muscles.

Group B

Patients in this group will receive Pursed-lip breathing along with pharmacological management for 3 weeks.

Two sessions per weeek will be supervised by physiotherapist and 5 days at home.

A home diary will be provided in order to ensure and follow-up of the participants that they are performing breathing exercises at home.

Group Type EXPERIMENTAL

Pursed-lip breathing along with pharmacological management

Intervention Type PROCEDURE

Patient in this group will receive pursed-lip breathing along with pharmacological management. A total 3 weeks protocol will be followed in which 2 sessions per week will be supervised by physiotherapist and 5 days at home.

The patient will sit comfortably with straight back and relaxed shoulders. They will inhale slowly through the nose, with a deep relaxed breath, and then exhale slowly through the pursed lips, as if blowing out a candle. The exhalation should take 2-3 times longer than inhalation. This breathing cycle will be repeated with a focus on slow and relaxed breathing.

Pharmacological management: Patient will receive medications as per prescribed by pulmonologist

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pilates Breathing Technique along with standard pharmacological management

Patients in this group will receive pilates breathing technique along with pharmacological management.

A total 3 weeks protocol will be followed in which 2 seesions per week will be supervised by physiotherapist and 5 days at home.

Pilates breathing will be performed in sitting or supine position. The patient will place a hand over the Lower Posterior rib Cage and inhale through the nose.

While breathing they will actively contract the Transverse Abdominis (TrA) as if preparing for punch or holding in urine and engaging the pelvic floor muscles.

Intervention Type PROCEDURE

Pursed-lip breathing along with pharmacological management

Patient in this group will receive pursed-lip breathing along with pharmacological management. A total 3 weeks protocol will be followed in which 2 sessions per week will be supervised by physiotherapist and 5 days at home.

The patient will sit comfortably with straight back and relaxed shoulders. They will inhale slowly through the nose, with a deep relaxed breath, and then exhale slowly through the pursed lips, as if blowing out a candle. The exhalation should take 2-3 times longer than inhalation. This breathing cycle will be repeated with a focus on slow and relaxed breathing.

Pharmacological management: Patient will receive medications as per prescribed by pulmonologist

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 40-64 years
* Both genders (male and female)
* Grade 1-3 on mMRC scale of dyspnea
* COPD mild stage according to global initiative for chronic obstructive lung disease (GOLD) classification; Mild = FEV1 greater than or equal to 80% predicted

Exclusion Criteria

* Moderate, severe and very severe stage of COPD according to GOLD classification
* Patients having acute exerbation of COPD
* Patients diagnosed with acute infection
* Patients unable to follow command and instructions
Minimum Eligible Age

40 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Foundation University Islamabad

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Foundation University College of Physical Therapy, Islamabad, 44000

Rawalpindi, , Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sana Kalim, DPT

Role: CONTACT

03369169645

Zara Khalid, PhD

Role: CONTACT

03335415822

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FUI/CTR/2025/91

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.